PragmaClin Research Inc.: federal grants and contributions: 23 agreements; $1.7M value; 3 departments; 8 programs.
Assay record ASY-CA-00PUE2K1SC · Cite as: Assay Systems, “PragmaClin Research Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/pragmaclin-research-inc/
The project will enhance the Parkinson's Remote Interactive Monitoring System (PRIMS) Sofware and perform a trial to evaluate medical relevance.
PragmaClin Research Inc. will refine the machine learning module and validate the PRIMS software as a Parkinson's monitoring tool.
iCODE PRIMS is a Canada-Taiwan collaborative research and development project to deliver a commercial-ready system for objective assessment of motor symptoms in Parkinson's disease.
Development of a virtual system for determining Parkinson’s Disease progression.
Engage expertise to develop export plans for validation studies and regulatory approvals
Engage expertise to develop technical support plan to assist in validation efforts
Engage expertise to support activities in product design and commercialization planning
PragmaClin uses machine learning to provide objective, accurate data for managing Parkinson's Disease. We seek a hospital in Ireland to partner on a pilot study, evaluating the performance, safety, and commercialization potential of our PRIMS technology.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The youth will assist with back-end development work for the PRIMS software.
This project will allow PragmaClin to hire a Research Intern to provide assistance with the development and implementation of various validation trials to validate our PRIMS software.
This project supports the empirical data collection phase of automating Parkinson’s disease assessment using PRIMS (PragmaClin Intelligent Motor System).
The Firm will strengthen its evidence generation and data reporting capabilities to support clinical pilots and the responsible growth of its neurological assessment platform, PRIMS.
The Firm will strengthen operational capacity to execute clinical pilots and healthcare partnerships for its neurological assessment platform, PRIMS.
The PRIMS Motor Assessment Expansion and Clinical Readout Enhancement project aims to implement features that will allow us to target additional types of neurological tests, collect additional data and information to allow the company to extract validity and clinical utility details, and prepare the system for deployment in various clinical environments.
The project involves researching the market for remote patient monitoring technology; analyzing the market, focusing on neurological disease; determining competitive advantages of our technology; and preparing a strategy for market penetration, as well as the business model and pricing structure for PRIMS (Parkinson's Remote Interactive Monitoring System), which is our product.
The project will support development of intellectual property capacity within the firm.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The Project will support development of intellectual property capacity within the Firm.
Participation in the Canadian AI solutions for health technologies (aging tech) co-innovation mission to Japan - December 2-5, 2024. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to explore the Japanese market and to develop international partnerships and potential project ideas under the Japan Program. In Partnership with the Trade Commissioner Service Canadian Technology Accelerator (TCS CTA), the Canadian delegation will also receive coaching and mentoring by industry leaders, support for their international business and market-e
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.